C3 and myocarditis: This did not affect the onset or severity of myocarditis in those Stat3C/C mice already showing high C3 or anti-α-myosin antibodies at the time of treatment, in agreement with the predicted role of C3 in the inductive phase (Supporting Information Fig S4A and B and Fig 7C).